Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Hyun Y. Park"'
Autor:
Alena Kamenshchikova, Petra F. G. Wolffs, Christian J. P. A. Hoebe, John Penders, Hyun Y. Park, Mateus S. Kambale, Klasien Horstman
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Antimicrobial resistance (AMR) is a global public health concern that requires transdisciplinary and bio-social approaches. Despite the continuous calls for a transdisciplinary understanding of this problem, there is still a lack
Externí odkaz:
https://doaj.org/article/0bffb56bceab414ab74b2bfc08c62992
Autor:
Anders Berglund, Ernest K. Amankwah, Young‐Chul Kim, Philippe E Spiess, Wade J. Sexton, Brandon Manley, Hyun Y. Park, Liang Wang, Jad Chahoud, Ratna Chakrabarti, Chang D. Yeo, Hung N. Luu, Giuliano D. Pietro, Alexander Parker, Jong Y. Park
Publikováno v:
Cancer Medicine, Vol 9, Iss 22, Pp 8662-8675 (2020)
Abstract Approximately 10%‐20% of patients with clinically localized clear cell renal cell carcinoma (ccRCC) at time of surgery will subsequently experience metastatic progression. Although considerable progression was seen in the systemic treatmen
Externí odkaz:
https://doaj.org/article/f3045cd0f0e24871a53ce3dfcb86f850
Autor:
Shelby L. Johnson, Hyun Y. Park, Nicholas A. DaSilva, Dhiraj A. Vattem, Hang Ma, Navindra P. Seeram
Publikováno v:
Nutrients, Vol 10, Iss 9, p 1139 (2018)
Mucuna pruriens (Mucuna) has been prescribed in Ayurveda for various brain ailments including ‘kampavata’ (tremors) or Parkinson’s disease (PD). While Mucuna is a well-known natural source of levodopa (L-dopa), published studies suggest that ot
Externí odkaz:
https://doaj.org/article/f65f866085794cf089785bf875861bd5
Autor:
L. Michael Carastro, Hui-Yi Lin, Hyun Y. Park, Donghwa Kim, Selina Radlein, Kaia K. Hampton, Ardeshir Hakam, Babu Zachariah, Julio Pow-Sang, Jong Y. Park
Publikováno v:
Prostate Cancer, Vol 2014 (2014)
Background. Molecular markers for prostate cancer (PCa) risks are currently lacking. Here we address the potential association of a dinucleotide polymorphism (DNP) in exon 2 of the p73 gene with PCa risk/progression and discern any disruption of p73
Externí odkaz:
https://doaj.org/article/6b0a7f2740c64cc1bea2fec45552f355
Autor:
Xiaoyin Li, Siddhartha Roy, Jennifer Damonte, Hyun Y. Park, Aasha I. Hoogland, Kala Jamison, Khaled R. Komrokji, Chang Dong Yeo, Youngchul Kim, Jasreman Dhillon, Lisa M. Gudenkauf, Laura B. Oswald, Heather S.L. Jim, Kosj Yamoah, Julio M. Pow-Sang, Peter A. Kanetsky, Clement K. Gwede, Jong Y. Park, Brian D. Gonzalez
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:768-775
Background: Prostate cancer affects African American men disproportionately compared with men of other racial/ethnic groups. To identify biological bases for this health disparity, we sought to create a state-wide biobank of African American prostate
Autor:
Jong Y. Park, Cecile A. Lengacher, Richard R. Reich, Hyun Y. Park, Junmin Whiting, Anh Thy Nguyen, Carmen Rodríguez, Hongdao Meng, Sara Tinsley, Katterine Chauca, Liliana Gordillo-Casero, Trudy Wittenberg, Anisha Joshi, Katherine Lin, Roohi Ismail-Khan, John V. Kiluk, Kevin E. Kip
Publikováno v:
Biological research for nursing. 24(4)
Introduction: Emerging evidence suggests that Chemotherapy (CT) treated breast cancer survivors (BCS) who have “risk variants” in genes may be more susceptible to cognitive impairment (CI) and/or poor cardiac phenotypes. The objective of this pre
Autor:
Jong Y. Park, Nagi Kumar, Robert W. Engelman, Ya-Yu Tsai, Junsung Choi, Arig Ibrahim Hashim, Ganna Chornokur, Heather Cornnell, Maria Rincon, Hyun Y. Park, Shahnjayla Connors, Ernest Amankwah, Seung Joon Kim
PDF file - 65K, Supplemental Figure 1. Body and prostate gland weights of C57BL/6J and TRAMP mice: A. Body weight change of C57BL/6J. B. Prostate weight of C57BL/6J. C. Body weight change of TRAMP. D. Prostate weight of TRAMP. Supplemental Figure 2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f4e143e9213e98a0105e7932af6fee2
https://doi.org/10.1158/1940-6207.22525139
https://doi.org/10.1158/1940-6207.22525139
Autor:
Jong Y. Park, Nagi Kumar, Robert W. Engelman, Ya-Yu Tsai, Junsung Choi, Arig Ibrahim Hashim, Ganna Chornokur, Heather Cornnell, Maria Rincon, Hyun Y. Park, Shahnjayla Connors, Ernest Amankwah, Seung Joon Kim
Prostate cancer treatment is often accompanied by untoward side effects. Therefore, chemoprevention to reduce the risk and inhibit the progression of prostate cancer may be an effective approach to reducing disease burden. We investigated the safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ff9ae2b6ead3f2e146927f3f230a782
https://doi.org/10.1158/1940-6207.c.6544595
https://doi.org/10.1158/1940-6207.c.6544595
Autor:
Jong Y. Park, Nagi Kumar, Robert W. Engelman, Ya-Yu Tsai, Junsung Choi, Arig Ibrahim Hashim, Ganna Chornokur, Heather Cornnell, Maria Rincon, Hyun Y. Park, Shahnjayla Connors, Ernest Amankwah, Seung Joon Kim
PDF file - 58K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bf0f281fcb17721ed8ec7bc6a763a12
https://doi.org/10.1158/1940-6207.22525142.v1
https://doi.org/10.1158/1940-6207.22525142.v1
Autor:
Jad Chahoud, Brandon J. Manley, Ernest K. Amankwah, Jong Y. Park, Wade J. Sexton, Hung N. Luu, Hyun Y. Park, Young-Chul Kim, Alex M. Parker, Liang Wang, Anders Berglund, Chang D. Yeo, Philippe E. Spiess, Giuliano Di Pietro, Ratna Chakrabarti
Publikováno v:
Cancer Medicine, Vol 9, Iss 22, Pp 8662-8675 (2020)
Cancer Medicine
Cancer Medicine
Approximately 10%‐20% of patients with clinically localized clear cell renal cell carcinoma (ccRCC) at time of surgery will subsequently experience metastatic progression. Although considerable progression was seen in the systemic treatment of meta